v3.19.3.a.u2

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2019	Sep. 30, 2019
Current assets:
Cash and cash equivalents	$ 12,575	$ 5,423
Accounts receivable:
Trade accounts receivable	676	3,451
Other receivables	878	174
Inventories		4,871
Prepaid expenses		217
Restricted cash	4,750
Total current assets	18,879	14,136
Property and equipment, net		35,662
Other assets	902	902
Total assets	19,781	50,700
Current liabilities:
Accounts payable	890	3,908
Accrued expenses	1,806	2,326
Current portion of long-term debt (stated principal amount of $0 and $29,812 at December 31, 2019 and September 30, 2019, respectively)		29,593
Total current liabilities	2,696	35,827
Other liabilities	14	1,027
Total liabilities	2,710	36,854
Members' equity:
Members' capital, no par value, 25,410,851 units issued and outstanding	44,826	44,826
Accumulated deficit	(27,755)	(30,980)
Total members' equity	17,071	13,846
Total liabilities and members' equity	$ 19,781	$ 50,700

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Advanced BioEnergy, LLC 10-Q